SlideShare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our User Agreement and Privacy Policy.
SlideShare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our Privacy Policy and User Agreement for details.
Successfully reported this slideshow.
Activate your 14 day free trial to unlock unlimited reading.
Presentation by Şerif BOYACI, pharmacist, Turkish Pharmacists' Association on Medical Transparency: The Turkish Case, during the 69th FIP Congress, Istanbul, September 2009.
Communication & Capacity Strengthening Director
at
Medicines Transparency Alliance (MeTA)
Presentation by Şerif BOYACI, pharmacist, Turkish Pharmacists' Association on Medical Transparency: The Turkish Case, during the 69th FIP Congress, Istanbul, September 2009.
1.
Medical Transparency: The Turkish Case Şerif BOYACI, pharmacist Turkish Pharmacists' Association
2.
Transperancy in determination of the price <ul><li>Two different prices: </li></ul><ul><li>Public price </li></ul><ul><li>Retail price </li></ul><ul><li>Strict regulations in determination of public price: </li></ul><ul><li>The cheapest of reference countries </li></ul><ul><li>The cheapest within the theraupatic class. </li></ul><ul><li>Positive list </li></ul><ul><li>Co-payment of patient. </li></ul><ul><li>Retail price: </li></ul><ul><li>Fixed margin rates for wholesalers and pharmacists </li></ul>
3.
Cost estimation <ul><li>Cost estimation for public bodies </li></ul><ul><li>Global budget (will be implemented for the year 2009) </li></ul><ul><li>Cost estimation of the patient </li></ul><ul><li>Standard co-payment as a tool for awareness of the drug prices </li></ul><ul><li>Extra payment for the drugs exceeding the reimbursement limit. </li></ul>
4.
The right of patient to obtain drug information <ul><li>The Regulation on the Patient Rights that ensures the right of the patient to access the drug information . </li></ul><ul><li>“ Short drug information” available via website of Ministry of Health. </li></ul><ul><li>The counselling services of the pharmacists. </li></ul>
5.
The right of patient to have access to drugs <ul><li>Again, The Regulation on the Patient Rights ensures the right to access the drugs. </li></ul><ul><li>The General Social Insurance System, subsumes all the citizens and non-citizens </li></ul><ul><li>The extensiveness of the pharmacies is guaranteeing the access. </li></ul>
6.
Transparency and privacy <ul><li>Privacy of the patient information is guaranteed by the laws. </li></ul><ul><li>But as an implementation of e-health systems, the Smartcard application is planned to be started at January 2010, on which we have doubts about the security of the patient information. </li></ul>
7.
The sustainability of pharmaceutical services <ul><li>The guarantee of the sustainability is the continuum of reimbursement system. </li></ul><ul><li>Turkey is the third most hit country by the global economic crisis. </li></ul><ul><li>Social security expenses are already exceeding the budget. </li></ul><ul><li>By generalisation of the social security system, the Institution pays the contribution of the unemployed (whose number reaches the 14.5% of the population), people below the age of 18, and people with low income. </li></ul>
0 likes
Be the first to like this
Views
Total views
1,537
On SlideShare
0
From Embeds
0
Number of Embeds
5
You have now unlocked unlimited access to 20M+ documents!
Unlimited Reading
Learn faster and smarter from top experts
Unlimited Downloading
Download to take your learnings offline and on the go
You also get free access to Scribd!
Instant access to millions of ebooks, audiobooks, magazines, podcasts and more.
Read and listen offline with any device.
Free access to premium services like Tuneln, Mubi and more.